000			01495 a2200457 4500
005			20250511165811.0
264		0	_c19750527
008			197505s 0 0 eng d
022			_a0090-4295
024	7		_a10.1016/0090-4295(75)90142-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aGriffith, D P
245	0	0	_aAcetohydroxamic acid. Potential use in urinary infection caused by urea-splitting bacteria. _h[electronic resource]
260			_bUrology _cMar 1975
300			_a299-302 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcetamides _xmetabolism
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aBacteria _xenzymology
650	0	4	_aBinding Sites
650	0	4	_aChemical Phenomena
650	0	4	_aChemistry
650	0	4	_aDogs
650	0	4	_aEnzyme Inhibitors
650	0	4	_aHumans
650	0	4	_aHydroxamic Acids _xmetabolism
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aIntestine, Small _xmetabolism
650	0	4	_aLiver Cirrhosis _xdrug therapy
650	0	4	_aMice
650	0	4	_aThymidine _xmetabolism
650	0	4	_aThymus Gland _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aUrease _xantagonists & inhibitors
650	0	4	_aUrinary Calculi _xdrug therapy
650	0	4	_aUrinary Tract Infections _xdrug therapy
700	1		_aMusher, D M
773	0		_tUrology _gvol. 05 _gno. 3 _gp. 299-302
856	4	0	_uhttps://doi.org/10.1016/0090-4295(75)90142-9 _zAvailable from publisher's website
999			_c1125685 _d1125685